Funding for this research was provided by:
German Research Council (BR 1704/17-1, HE 5998/2-1, RO 2270/8-1, KL 2354/3-1, CH 117/1-1, BR 1704/6-4, BR 1704/6-3, BR 1704/6-1, HO 5117/2-1)
DKFZ-Heidelberg Center for Personalized Oncology (DKFZ-HIPO, H052)
German Federal Ministry of Education and Research (01ER1505B, 01ER0815, 01ER1505A, 01ER0814, 01KH0404)
National Center for Tumor Diseases (H109)
Text and Data Mining valid from 2019-07-24
Received: 10 May 2019
Accepted: 11 July 2019
First Online: 24 July 2019
Ethics approval and consent to participate
: The study was approved by the ethics committees of the Medical Faculty of the University of Heidelberg (310/2001) and of the State Medical Boards of Baden–Wuerttemberg (M-198-02) and Rhineland–Palatinate (837.419.02 (3637)).
: Not applicable
: The authors declare that they have no competing interests.